Kenneth Jones, MD
Adult Medicine · Union City, GANPI 1417018920
Payments from drug & device makers
Across 530 payments — averaging $16.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- AstraZeneca$1K
- Sanofi-aventis U.S. LLC$879
- Novo Nordisk$735
- Lilly USA, LLC$582
- Boehringer Ingelheim$395
- plus $4K from 43 others
What the payments were for
- Food & beverage$8,64299%
- Education$851%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
$8,727 in reported general payments places this provider in the 85th percentile of 43 adult medicine providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 103 | $69,235 |
| OzempicSemaglutide | 45 | $50,565 |
| MounjaroTirzepatide | 38 | $42,773 |
| TrulicityDulaglutide | 31 | $38,535 |
| Soliqua 100-33Insulin Glargine/Lixisenatide | 34 | $35,637 |
| LinzessLinaclotide | 42 | $33,320 |
| EliquisApixaban | 31 | $24,148 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 26 | $18,740 |
| Janumet XrSitagliptin Phos/Metformin Hcl | 22 | $17,719 |
| RybelsusSemaglutide | 11 | $17,451 |
| GlyxambiEmpagliflozin/Linagliptin | 15 | $17,136 |
| FarxigaDapagliflozin Propanediol | 29 | $16,035 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 13 | $13,769 |
| XareltoRivaroxaban | 11 | $12,539 |
| JanuviaSitagliptin Phosphate | 21 | $9,549 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance, Glyxambi | $395 | $86,371118 claims |
| Lilly USA, LLCMounjaro, Trulicity | $582 | $81,30869 claims |
| Novo NordiskOzempic, Rybelsus | $735 | $68,01656 claims |
| Sanofi-aventis U.S. LLCSoliqua 100-33 | $879 | $35,63734 claims |
| AstraZenecaBreztri Aerosphere, Farxiga | $1,018 | $34,77555 claims |
| AbbVieLinzess | $1,061 | $33,32042 claims |
| MerckJanumet Xr, Januvia | $157 | $27,26843 claims |
| PfizerEliquis | $361 | $24,14831 claims |
| GSKTrelegy Ellipta | $174 | $13,76913 claims |
| Johnson & JohnsonXarelto | $50 | $12,53911 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 43 adult medicine providers in Georgia.
Other adult medicine in Union City
- Phillip NowlinCarrollton$1.2M
- Jinne RichardsAlbany$85K
- Michael CohenPooler$14K
- Charles WilliamsAlpharetta$10K
- Robert DillonDoraville$9K
- Katherine McClellanRinggold$7K
- Ewaul PersaudSmyrna$6K
- Jenna Barnes CaronDalton$5K
- Alana VilladaBuford$4K
- Syed UllahDecatur$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.